Skip to content

ASTHMA-Educator Mobile Application Manage Asthma

The ASTHMA-Educator: A Novel Algorithmic Software Tool to Help Manage Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03518879
Enrollment
70
Registered
2018-05-08
Start date
2015-03-31
Completion date
2021-07-01
Last updated
2023-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

informatics, asthma

Brief summary

Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use among adult asthma patients at Montefiore.

Detailed description

Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use through 2 phases: 1) Phase 1 = process outcomes evaluation with 30 patients); and 2) Phase 2 (longitudinal clinical evaluation with 40 patients receiving the intervention at baseline, 2 months, 4 months, and 6 months). The study's primary outcome is asthma control.

Interventions

OTHERASTHMA-Educator mobile application

The on-site delivered ASTHMA-Educator mobile application.

Sponsors

Montefiore Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This is a single-arm proof of concept study to evaluate the impact of the ASTHMA-Educator on process and clinical outcomes

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults (\>18 years) with: (a) severe asthma (i.e. at least one asthma-related ED visit and/or hospitalization in the previous year); (b) access to a smartphone with short message service (SMS) capability; (c) English speaking; (d) able to give informed consent.

Exclusion criteria

(a) use of oral corticosteroids in the 2 weeks prior to the baseline visit; (b) pregnancy; (c) severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol; and (d) patients that previously received the ASTHMAXcel application.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline asthma control to 2, 4, and 6 monthsBaseline, 2 months, 4 months, 6 monthsAsthma symptom burden as measured by the Asthma Control Test

Secondary

MeasureTime frameDescription
Patient satisfaction measured by the Client Satisfaction Questionnaire-8Immediately post-intervention at the baseline visit, 2 months, 4 months, 6 monthsPatient satisfaction measured by the Client Satisfaction Questionnaire-8
Time spent in using the mobile applicationImmediately post-intervention at the baseline visitTime spent in using the mobile application
Asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)Baseline, 2 months, 4 months, 6 monthsPatients' asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)
Change from baseline asthma knowledge to immediately post-intervention, 2 months, 4 months, and 6 monthsBaseline, immediately post-intervention, 2 months, 4 months, 6 monthsAsthma knowledge as measured by the validated Asthma Knowledge Questionnaire
Asthma hospitalizationsBaseline, 2 months, 4 months, 6 monthsAsthma hospitalizations
Asthma-related steroid coursesBaseline, 2 months, 4 months, 6 monthsAsthma-related steroid courses
Asthma emergency department visitsBaseline, 2 months, 4 months, 6 monthsAsthma emergency department visits

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026